Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus lidocaine for sedation during mandibular impacted wisdom tooth surgery
IRCT20200406046966N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Dexmedetomidine + lidocaine with epinephrine with Lidocaine with epinephrine control (2 arms). Primary endpoints: Patient's sedation and Surgeon's satisfaction. Started Apr 2020; status: completed.
02
Drugs
dexmedetomidinelidocaineepinephrine
Beyond the preview
Go deeper on IRCT20200406046966N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200406046966N1.